Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists |
Mechanism AVPR1A antagonists(Vasopressin V1a receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC24H25ClN4O3 |
InChIKeyLFXCGLFTXRJJLT-RUCARUNLSA-N |
CAS Registry2355304-05-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nervous System Diseases | Discovery | Hungary | 02 Jan 2024 |